UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2019-10, Vol.17 (10), p.1772-1778

2019

Volltextzugriff (PDF)

Anticoagulation of cancer patients with non‐valvular atrial fibrillation receiving chemotherapy: Guidance from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2019-08, Vol.17 (8), p.1247-1252

2019

Volltextzugriff (PDF)

Survival in patients with cancer‐associated thrombosis in relation to anticoagulants: Re‐vitalization of warfarin?

Journal of thrombosis and haemostasis, 2021-11, Vol.19 (11), p.2677-2679

Wang, Tzu‐Fei

2021

Volltextzugriff (PDF)

Thromboprophylaxis in patients with multiple myeloma

British journal of haematology, 2020-08, Vol.190 (4), p.493-494

2020

Volltextzugriff (PDF)

Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post‐hoc analysis of the Hokusai‐VTE Cancer study

Journal of thrombosis and haemostasis, 2019-11, Vol.17 (11), p.1866-1874

2019

Volltextzugriff (PDF)

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

The New England journal of medicine, 2018-02, Vol.378 (7), p.615-624

2018

Volltextzugriff (PDF)

Outcomes among patients with cancer and incidental or symptomatic venous thromboembolism: A systematic review and meta‐analysis

Journal of thrombosis and haemostasis, 2021-10, Vol.19 (10), p.2468-2479

2021

Volltextzugriff (PDF)

Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score

American journal of hematology, 2019-11, Vol.94 (11), p.1176-1184

2019

Volltextzugriff (PDF)

Management strategies in persons with inherited haemophilia requiring antithrombotic therapy: A scoping review

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-01, Vol.30 (1), p.16-50

2024

Volltextzugriff (PDF)

Immune Checkpoint Inhibitors-Associated Thrombosis: Incidence, Risk Factors and Management

Current oncology (Toronto), 2023-03, Vol.30 (3), p.3032-3046

2023

Volltextzugriff (PDF)

Characteristics and outcomes of patients on concurrent direct oral anticoagulants and targeted anticancer therapies—TacDOAC registry: Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy

Journal of thrombosis and haemostasis, 2021-08, Vol.19 (8), p.2068-2081

2021

Volltextzugriff (PDF)

Inherited thrombophilia gene mutations and risk of venous thromboembolism in patients with cancer: A systematic review and meta‐analysis

American journal of hematology, 2024-04, Vol.99 (4), p.577-585

2024

Volltextzugriff (PDF)

The prevention and management of asparaginase‐related venous thromboembolism in adults: Guidance from the SSC on Hemostasis and Malignancy of the ISTH

Journal of thrombosis and haemostasis, 2020-02, Vol.18 (2), p.278-284

2020

Volltextzugriff (PDF)

Peri‐procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: Guidance from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2022-12, Vol.20 (12), p.3026-3038

2022

Volltextzugriff (PDF)

Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study

Thrombosis and haemostasis, 2018-08, Vol.118 (8), p.1439-1449

2018

Volltextzugriff (PDF)

Increased bleeding risk associated with concurrent vascular endothelial growth factor receptor tyrosine kinase inhibitors and low‐molecular‐weight heparin

Cancer, 2021-03, Vol.127 (6), p.938-945

2021

Volltextzugriff (PDF)

Management of hemostatic complications in acute leukemia: Guidance from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2020-12, Vol.18 (12), p.3174-3183

2020

Volltextzugriff (PDF)

Approach to Cancer‐Associated Thrombosis: Challenging Situations and Knowledge Gaps

The oncologist (Dayton, Ohio), 2021-01, Vol.26 (1), p.e17-e23

2021

Volltextzugriff (PDF)

Standardization of risk prediction model reporting in cancer‐associated thrombosis: Communication from the ISTH SSC subcommittee on hemostasis and malignancy

Journal of thrombosis and haemostasis, 2022-08, Vol.20 (8), p.1920-1927

2022

Volltextzugriff (PDF)

Risk of venous thromboembolism or hemorrhage among individuals with chronic kidney disease on prophylactic anticoagulant after hip or knee arthroplasty

American journal of hematology, 2023-09, Vol.98 (9), p.1374-1382

2023

Volltextzugriff (PDF)

Inferior vena cava filter use at a large community hospital: a retrospective cohort study

Scientific reports, 2024-05, Vol.14 (1), p.10192-10192, Article 10192

2024

Volltextzugriff (PDF)

Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban

Journal of thrombosis and haemostasis, 2021-12, Vol.19 (12), p.3008-3017

2021

Volltextzugriff (PDF)

How to treat incidental pulmonary embolism in cancer patients? Recent advances

Kardiologia polska, 2021-12, Vol.79 (12), p.1305-1310

2021

Volltextzugriff (PDF)

Managing thrombosis in cancer patients

Research and practice in thrombosis and haemostasis, 2018-07, Vol.2 (3), p.429-438

2018

Volltextzugriff (PDF)

Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis Day

Journal of thrombosis and haemostasis, 2022-12, Vol.20 (12), p.2964-2971

2022

Volltextzugriff (PDF)

1 – 25 von 180

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(174)
Mit Volltextzugriff
(157)

Publikationsform

Sprache

Englisch
(180)

Erscheinungsjahr

n.n

Thema

Science & Technology
(106)
Life Sciences & Biomedicine
(105)
Hematology
(78)
Cardiovascular System & Cardiology
(61)
Humans
(60)
Peripheral Vascular Disease
(57)
Venous Thromboembolism
(47)
Anticoagulants
(31)
Cancer
(31)
Thrombosis
(31)
Thromboembolism
(26)
Female
(23)
Neoplasms - Complications
(22)
Venous Thromboembolism - Drug Therapy
(22)
Anticoagulants - Adverse Effects
(21)
Male
(21)
Risk Factors
(21)
Venous Thromboembolism - Etiology
(21)
Venous Thromboembolism - Prevention & Control
(21)
Adult
(19)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH

Anticoagulation of cancer patients with non‐valvular atrial fibrillation receiving chemotherapy: Guidance from the SSC of the ISTH

Survival in patients with cancer‐associated thrombosis in relation to anticoagulants: Re‐vitalization of warfarin?

Thromboprophylaxis in patients with multiple myeloma

Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post‐hoc analysis of the Hokusai‐VTE Cancer study

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

Outcomes among patients with cancer and incidental or symptomatic venous thromboembolism: A systematic review and meta‐analysis

Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score

Management strategies in persons with inherited haemophilia requiring antithrombotic therapy: A scoping review

Immune Checkpoint Inhibitors-Associated Thrombosis: Incidence, Risk Factors and Management

Characteristics and outcomes of patients on concurrent direct oral anticoagulants and targeted anticancer therapies—TacDOAC registry: Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy

Inherited thrombophilia gene mutations and risk of venous thromboembolism in patients with cancer: A systematic review and meta‐analysis

The prevention and management of asparaginase‐related venous thromboembolism in adults: Guidance from the SSC on Hemostasis and Malignancy of the ISTH

Peri‐procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: Guidance from the SSC of the ISTH

Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study

Increased bleeding risk associated with concurrent vascular endothelial growth factor receptor tyrosine kinase inhibitors and low‐molecular‐weight heparin

Management of hemostatic complications in acute leukemia: Guidance from the SSC of the ISTH

Approach to Cancer‐Associated Thrombosis: Challenging Situations and Knowledge Gaps

Standardization of risk prediction model reporting in cancer‐associated thrombosis: Communication from the ISTH SSC subcommittee on hemostasis and malignancy

Risk of venous thromboembolism or hemorrhage among individuals with chronic kidney disease on prophylactic anticoagulant after hip or knee arthroplasty

Inferior vena cava filter use at a large community hospital: a retrospective cohort study

Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban

How to treat incidental pulmonary embolism in cancer patients? Recent advances

Managing thrombosis in cancer patients

Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis Day

Suchergebnisse filtern